Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jazz Pharmaceuticals Sees FY24 Adj. EPS $18.15-$19.35 Vs $19.94 Est.; Revenue $4.00B-$4.20B Vs $4.088B Est.

Author: Benzinga Newsdesk | February 28, 2024 05:19pm

Posted In: JAZZ